<DOC>
	<DOC>NCT00963599</DOC>
	<brief_summary>This study will evaluate the ability of oral montelukast/loratadine to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine alone, montelukast alone and placebo.</brief_summary>
	<brief_title>Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient has a documented history of seasonal allergic rhinitis symptoms that flare up during the study season Patient is a nonsmoker Patient is in good general health Patient is hospitalized Patient is a woman who is less than 8 weeks postpartum or is breastfeeding Patient intends to move or vacation away during the study Patient has had any major surgery within 4 weeks of study start Patient is a current or past abuser of alcohol or illicit drugs Patient has been treated in an emergency room for asthma in the past month Patient had an upper respiratory infection with in 3 weeks prior to study start Patient has any active pulmonary disorder other than asthma</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>